Acute exacerbation of idiopathic pulmonary fibrosis: role of Chlamydophila pneumoniae infection

Respirology. 2007 Sep;12(5):700-6. doi: 10.1111/j.1440-1843.2007.01119.x.

Abstract

Background and objectives: Patients with idiopathic pulmonary fibrosis (IPF) may experience acute exacerbations of their illness. The actual trigger(s) of such exacerbations is unknown. Chlamydophila pneumoniae infection can cause exacerbation of asthma and COPD. A prospective study was conducted to investigate the possible role of C. pneumoniae infection in triggering acute exacerbations of IPF.

Methods: A prospective observational study over 5 years of consecutive IPF patients who fulfilled the criteria for acute exacerbation. Sputum, blood cultures and acute and convalescent serology for C. pneumoniae IgG and IgA (ELISA) were performed.

Results: Previous infection with C. pneumoniae is common. Of the 27 study patients, 15 had a C. pneumoniae IgG index of 1.10-2.99 (positive) and 3 had a C. pneumoniae IgG index of >2.99 (strongly positive) at the time of presentation with an acute exacerbation. In addition, 15 subjects had a C. pneumoniae IgA index of 1.10-2.99 (positive) and 6 subjects had a C. pneumoniae IgA index of >2.99 (strongly positive). However, only two of the 15 subjects (13%) for whom paired sera were tested exhibited a significant rise in antibody response (change in index of 1.90 for C. pneumoniae IgG and 1.54 for IgA, respectively) indicating either acute or reactivated infection with C. pneumoniae. There were 15 deaths (56%) despite supportive care that included high-dose corticosteroid therapy and oxygen supplementation.

Conclusions: Mortality is high with acute exacerbation of IPF. Acute infection with C. pneumoniae is uncommon at the time of presentation with acute exacerbation of IPF.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Bacterial / analysis
  • Chlamydophila Infections / complications*
  • Chlamydophila Infections / diagnostic imaging
  • Chlamydophila Infections / drug therapy
  • Chlamydophila Infections / mortality
  • Chlamydophila pneumoniae* / immunology
  • Female
  • Glucocorticoids / administration & dosage
  • Humans
  • Male
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Prospective Studies
  • Pulmonary Fibrosis / diagnostic imaging
  • Pulmonary Fibrosis / drug therapy
  • Pulmonary Fibrosis / microbiology*
  • Pulmonary Fibrosis / mortality
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Bacterial
  • Glucocorticoids
  • Methylprednisolone